HopeStage
Back to all studies
CompletedNCT05741710

Methylone safety and treatment research for adults with PTSD

About this titleRead the official source — NCT05741710

Researchers compared Methylone and placebo to find out how the approaches affected post-traumatic stress symptoms in people with PTSD.

Medication studyAges 18–65Multiple countries
The study in practice

Understand this study

What did researchers investigate?

Researchers compared Methylone and placebo to find out how the approaches affected post-traumatic stress symptoms in people with PTSD.

Who was this study for?

This study was for people with PTSD. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.

Listed locations
Denver and 15 more locationsSee all locations and recruitment
Study phase
Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: March 1, 2023
Recruitment status
Completed
Enrollment listed in the registry
79
Sponsor
Transcend Therapeutics
Sponsor type
Biotech company
Study type
Drug
Intervention type
Drug
Study phase
Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Locations
United States, United Kingdom, Ireland
Age range
From 18 Years to 65 Years
Official registry ID
NCT05741710
Official title
Show the full official title

A Pilot Study to Assess the Use of Methylone in the Treatment of PTSD IMPACT-1 (Investigation of Methylone for Post-Traumatic Stress Disorder [PTSD])

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Denver, United States · Jacksonville, United States · Maitland, United States

12 more locations
  • Rockville, United States
  • Boston, United States
  • Berlin, United States
  • Oklahoma City, United States
  • Murray, United States
  • Dublin, Ireland
  • Galway, Ireland
  • Belfast, United Kingdom
  • Cambridge, United Kingdom
  • Glasgow, United Kingdom
  • London, United Kingdom
  • Oxford, United Kingdom

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

What did researchers investigate?

Researchers compared Methylone and placebo to find out how the approaches affected post-traumatic stress symptoms in people with PTSD.

Who is behind this study?

The study sponsor is Transcend Therapeutics.

Did this study involve medication?

Yes. The study involved medication, including Methylone and Placebo.

Who was this study for?

This study was for people with PTSD. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies